TSH may not be a good marker for adequate thyroid hormone replacement therapy
Abstract
The objective of this study was to evaluate parameters of thyroid function and indices of peripheral thyroid hormone action (such as SHBG) in patients whose hypothyroidism was considered well controlled under current criteria. Eighty-five patients with T4-treated hypothyroidism, 28 of whom had athyria, were compared with 114 normal individuals with the same TSH levels. T3 levels were significantly lower in hypothyroidism although mean T4 and fT4 levels were significantly higher. Furthermore, mean SHBG levels were significantly lower in hypothyroidism independently of age. The difference remained when stricter criteria for adequate treatment were applied (TSH < 2.5 microgU/ml). Significant negative correlations were found between logTSH and T3. The slopes of the regression lines of T3 to TSH were significantly different in the control group and the hypothyroid group: thus, for the same TSH levels, T3 levels were lower in the hypothyroid group. We conclude that patients with T4-treated hypothyroidism have lower T3 levels, lower T3/T4 ratio and lower SHBG than normal individuals with the same TSH, perhaps indicating relative tissue hypothyroidism in the liver. TSH levels used to monitor substitution, mostly regulated by intracellular T3 in the pituitary, may not be such a good indicator of adequate thyroid hormone action in all tissues. The co-administration of T3 may prove more effective in this respect, provided novel suitable preparations are developed. Until this is accomplished, substitution in hypothyroidism should aim at low normal TSH, to ensure normal T3 levels.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In athyreotic individuals treated with LT4 to achieve a normal serum TSH, serum T3 is either normal or lower than in normal individuals.
“Moreover, in athyreotic individuals treated with LT4 to achieve a normal serum TSH, the serum FT4 is usually higher and the serum T3 is either normal (38,39) or lower than the values seen in normal individuals (39-43).”
From Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014) · cites this paper as [43]
Because of tissue heterogeneity, pituitary TSH secretion may not reflect what happens in other target tissues, and therefore serum TSH alone may not be a good marker for the adequacy of thyroid hormone replacement.
“Because of tissue heterogeneity, pituitary TSH secretion may not reflect what happens in other target tissues, and therefore serum TSH alone may not be a good marker for the adequacy of thyroid hormone replacement [67,68,70] .”
From 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism (2012) · cites this paper as [68]
Serum T3 and free T3 concentrations are lower in L-T4-treated patients than in controls (T3 1.60 vs. 1.86 nmol/l, free T3 3.70 vs. 4.47 pmol/l, p < 0.001).
“These differences may be related to differences in serum T3 and free T3 concentrations, which are lower in L-T4-treated patients than in controls (T3 1.60 vs. 1.86 nmol/l, free T3 3.70 vs. 4.47 pmol/l, p ! 0.001) [67,68] .”
From 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism (2012) · cites this paper as [68]
Cites
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279 · see citing works
Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons
Sawin, C. T., Geller, A., Wolf, P. A., Belanger, A. J., Baker, E., Bacharach, P., Wilson, P., Benjamin, E. J., & D'Agostino, R. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311901 · Cited by 1,259 · cited 1× · see citing works
“It should be kept in mind that the studies reporting adverse effects of suppressed TSH referred to mixed populations, mostly patients with endogenous hyperthyroidism [26–28]; on the other hand, the adverse effect of exogenous T4 administration on bone mass is debated [29].”
BackgroundAndersen, S., Pedersen, K. M., Bruun, N. H., & Laurberg, P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8165 · Cited by 686 · see citing works
Saravanan, P., Chau, W. ‐., Roberts, N., Vedhara, K., Greenwood, R., & Dayan, C. M. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01654.x · Cited by 514 · see citing works
Bunevičius, R., Kažanavičius, G., Žalinkevičius, R., & Prange, A. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400603 · Cited by 482 · cited 2× · see citing works
“In the only study of patients with hypothyroidism where an increase in T3 levels was achieved by co-administration of T3, SHBG levels were significantly increased, supporting the view that thyroid status is the main factor responsible for lower SHBG [13].”
BackgroundThyroid-Pituitary Interaction: Feedback Regulation of Thyrotropin Secretion by Thyroid Hormones
Bleich, H. L., Moore, M. J., & Larsen, P. R. (1982) · New England Journal of Medicine · doi:10.1056/nejm198201073060107 · Cited by 357 · see citing works
The Deiodinase Family of Selenoproteins
GERMAIN, D. L. S., & GALTON, V. A. (1997) · Thyroid · doi:10.1089/thy.1997.7.655 · Cited by 342 · see citing works
American Thyroid Association Guidelines for Use of Laboratory Tests in Thyroid Disorders
Surks, M. I. (1990) · JAMA · doi:10.1001/jama.1990.03440110095035 · Cited by 274 · see citing works
Escobar-Morreale, H. F., del Rey, F. E., Obregón, M. J., & de Escobar, G. M. (1996) · Endocrinology · doi:10.1210/endo.137.6.8641203 · Cited by 261 · see citing works
Lekakis, J. P., Papamichael, C. M., Alevizaki, M. K., Gd, P., MARAFELIA, P., Mantzos, J. D., Stamatelopoulos, S., & Koutras, D. A. (1997) · Thyroid · doi:10.1089/thy.1997.7.411 · Cited by 236 · see citing works
Self-citationVanderpump, M. P. J., Ahlquist, J., Franklyn, J., & Clayton, R. (1996) · BMJ · doi:10.1136/bmj.313.7056.539 · Cited by 233 · see citing works
Toft, A. D. (2001) · New England Journal of Medicine · doi:10.1056/nejmcp010145 · Cited by 231 · see citing works
CARR, D., MCLEOD, D. T., PARRY, G., & THORNES, H. M. (1988) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1988.tb01219.x · Cited by 210 · see citing works
Walsh, J. P., Shiels, L., Lim, E. M., Bhagat, C. I., Ward, L. C., Stuckey, B. G. A., Dhaliwal, S. S., Chew, G. T., Bhagat, M. C., & Cussons, A. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030249 · Cited by 210 · see citing works
Clyde, P. W., Harari, A. E., Getka, E. J., & Shakir, K. M. M. (2003) · JAMA · doi:10.1001/jama.290.22.2952 · Cited by 195 · see citing works
Sawka, A. M., Gerstein, H. C., Marriott, M. J., MacQueen, G. M., & Joffe, R. T. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030139 · Cited by 175 · cited 1× · see citing works
“It should be noted that in some recent studies parameters of thyroid function were not always normal after the shift [21], that only patients with depressive symptoms were specifically examined [22] and that the number examined was small [20]; thus none of these studies can be considered conclusive [23].”
ResultLarsen, P. R., Dick, T. E., Markovitz, B. P., Kaplan, M. M., & Gard, T. G. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109430 · Cited by 149 · see citing works
REICHLIN, S., & UTIGER, R. D. (1967) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-27-2-251 · Cited by 114 · see citing works
Hennemann, G., Docter, R., Visser, T. J., Postema, P. T., & Krenning, E. P. (2004) · Thyroid · doi:10.1089/105072504323030924 · Cited by 90 · see citing works
Intrinsic imperfections of endocrine replacement therapy
Romijn, J., Smit, J., & Lamberts, S. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490091 · Cited by 85 · see citing works
Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations
Woeber, K. A. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03343972 · Cited by 67 · see citing works
Kaplan, M. M., Sarne, D. H., & Schneider, A. B. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031436 · Cited by 50 · see citing works
Meier, C., Trittibach, P. C., Guglielmetti, M., Staub, J.-J., & Müller, B. (2003) · BMJ · doi:10.1136/bmj.326.7384.311 · Cited by 44 · see citing works
Interpretation of Sex Hormone-Binding Globulin Levels in Thyroid Disorders
Hampl, R., Kancheva, R. L., Hill, M., Bičı́ková, M., & Vondra, K. (2003) · Thyroid · doi:10.1089/105072503768499644 · Cited by 42 · see citing works
Pallas, D., Koutras, D. A., Adamopoulos, P. N., Marafelia, P., Souvatzoglou, A., Piperingos, G. D., & Moulopoulos, S. D. (1991) · Journal of Endocrinological Investigation · doi:10.1007/bf03347907 · Cited by 37 · see citing works
Self-citationToft, A. D., & Beckett, G. J. (2003) · BMJ · doi:10.1136/bmj.326.7384.295 · Cited by 32 · see citing works
WEISSEL, M. (2001) · PubMed · Cited by 16 · see citing works
Relative ineffectiveness of exogenous triiodothyronine as a thyroid suppressive agent
Koutras, D. A., Malamitsi, J., Souvatzoglou, A., et al. (1981) · Journal of Endocrinological Investigation · doi:10.1007/bf03349455 · Cited by 8 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928 · see citing works
2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism
Wiersinga, W. M., Duntas, L., Fadeyev, V., Nygaard, B., & Vanderpump, M. P. J. (2012) · European Thyroid Journal · doi:10.1159/000339444 · Cited by 427 · see citing works
Panicker, V., Saravanan, P., Vaidya, B., Evans, J., Hattersley, A. T., Frayling, T. M., & Dayan, C. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1301 · Cited by 327 · see citing works
Levothyroxine Monotherapy Cannot Guarantee Euthyroidism in All Athyreotic Patients
Gullo, D., Latina, A., Frasca, F., Le Moli, R., Pellegriti, G., & Vigneri, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022552 · Cited by 307 · see citing works
Werneck de Castro, J. P., Fonseca, T. L., Ueta, C. B., McAninch, E. A., Abdalla, S., Wittmann, G., Lechan, R. M., Gereben, B., & Bianco, A. C. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77588 · Cited by 184 · see citing works
Ito, M., Miyauchi, A., Morita, S., Kudo, T., Nishihara, E., Kihara, M., Takamura, Y., Ito, Y., Kobayashi, K., Miya, A., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1029 · Cited by 133 · see citing works
Combination Treatment with T4 and T3: Toward Personalized Replacement Therapy in Hypothyroidism?
Biondi, B., & Wartofsky, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3399 · Cited by 124 · see citing works
Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism
Wiersinga, W. M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.258 · Cited by 114 · see citing works
Wouters, H. J. C. M., van Loon, H. C. M., van der Klauw, M. M., Elderson, M. F., Slagter, S. N., Kobold, A. M., Kema, I. P., Links, T. P., van Vliet-Ostaptchouk, J. V., & Wolffenbuttel, B. H. R. (2017) · Thyroid® · doi:10.1089/thy.2016.0199 · Cited by 97 · see citing works
McAninch, E. A., Rajan, K. B., Miller, C. H., & Bianco, A. C. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01361 · Cited by 94 · see citing works
Biochemical Markers Reflecting Thyroid Function in Athyreotic Patients on Levothyroxine Monotherapy
Ito, M., Miyauchi, A., Hisakado, M., Yoshioka, W., Ide, A., Kudo, T., Nishihara, E., Kihara, M., Ito, Y., Kobayashi, K., et al. (2017) · Thyroid · doi:10.1089/thy.2016.0426 · Cited by 91 · see citing works
Dayan, C., & Panicker, V. (2018) · Thyroid Research · doi:10.1186/s13044-018-0045-x · Cited by 62 · see citing works
THERAPY OF ENDOCRINE DISEASE: T4 + T3 combination therapy: is there a true effect?
Wiersinga, W. M. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0645 · Cited by 52 · see citing works
Ito, M., Miyauchi, A., Kang, S., Hisakado, M., Yoshioka, W., Ide, A., Kudo, T., Nishihara, E., Kihara, M., Ito, Y., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0138 · Cited by 51 · see citing works
Schmidt, U., Nygaard, B., Jensen, E. W., Kvetny, J., Jarløv, A., & Faber, J. (2013) · Endocrine Connections · doi:10.1530/ec-12-0064 · Cited by 17 · see citing works
Thyroid Hormone Transport into Cellular Tissue
Holtorf, K. (2014) · Journal of Restorative Medicine · doi:10.14200/jrm.2014.3.0104 · Cited by 16 · see citing works
Bjerkreim, B. A., Hammerstad, S. S., Gulseth, H. L., Berg, T. J., Lee-Ødegård, S., & Eriksen, E. F. (2022) · Journal of Thyroid Research · doi:10.1155/2022/6423023 · Cited by 8 · see citing works
- Authors
- Alevizaki, M., Mantzou, E., Cimponeriu, A. T., Alevizaki, C. C., & Koutras, D. A.
- Affiliations
- National and Kapodistrian University of Athens (GR)
- Evangelismos Hospital (GR)
- Corresponding author
- Alevizaki, Maria
- ORCID
- Alevizaki, Maria
- Venue
- Wiener klinische Wochenschrift
- Published
- 2005-09
- Volume
- 117
- Issue
- 18
- Pages
- 636-640
- ISSN
- 0043-5325 (ISSN-L)
- 1613-7671
- OpenAlex
- W77726133
- Cited by
- 34
- References
- 28
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 2 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 4 · 2016: 3 · 2015: 2 · 2014: 4 · 2013: 1 · 2012: 4
- FWCI
- 0.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Wiener klinische Wochenschrift (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- thyroid-stimulating hormone, hypothyroidism, thyroid hormone replacement, levothyroxine, triiodothyronine, sex hormone-binding globulin, T3/T4 ratio, liver, treatment monitoring
- MeSH terms
- Female, Greece, Humans, Hyperthyroidism, Male, Middle Aged, Prognosis, Sensitivity and Specificity, Statistics as Topic, Thyrotropin, Thyroxine, Triiodothyronine, Reproducibility of Results, Biomarkers, Treatment Outcome, Outcome Assessment, Health Care, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review